In a move that has sent shockwaves through the Indian medical device industry, former U.S. President Donald Trump has imposed a 26% reciprocal tariff on medical device exports from India. This decision, aimed at correcting perceived trade imbalances and promoting domestic manufacturing in the U.S.,
- No committee was formed to review the different tenets of the Bill: AIMED - If the Bill is passed as is for medical devices, India may be pushed into a supply chain crisis: Dr Giridhar Gyani, Secretary General, AHPI Consumer Patient groups, Healthcare Providers joined manufacturers
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
